Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
06/2005
06/07/2005US6903078 Applying wound healing agents comprising nucleotide sequences codes for platelet derived growth factors(PDGF), keratinocyte growth factors(KGF), insulin like growth factors(IGF) and insulin like growth factor binding proteins(IGFBP)
06/07/2005US6902908 Polypeptides, fusion proteins; includes production and use recombinant expression constructs having regulated promoter; mitochondria
06/07/2005US6902734 Also an IL-12 anti-idiotype antibody to the antibody
06/07/2005US6902731 Transcription factors; for arterial administration via stent
06/07/2005CA2320180C Cyclohexanediole derivatives
06/07/2005CA2299036C 4-phenyl-4-heteroarylpiperidine derivatives
06/07/2005CA2281090C Sulfonamide compounds and salts for treatment of endothelin-mediated disorders
06/07/2005CA2234113C Novel derivatives of salicylic acid and their use in a cosmetic and/or dermatological composition
06/02/2005WO2005049834A1 Cell activator, hair growth stimulant and hair growth promoter
06/02/2005WO2005049631A1 Synthetic molecules having immune activity
06/02/2005WO2005049060A1 Composition and method for treatment of acne
06/02/2005WO2005049054A1 Compositions and methods for the treatment of skin damage
06/02/2005WO2005049017A1 Anti-inflammatory, regenerating and antimicrobial composition
06/02/2005WO2005010027A3 Novel peptidic conjugates for alopecia preventive and curative treatment
06/02/2005WO2003090514A3 Adipocyte complement related protein zacrp14
06/02/2005WO2003075847A3 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
06/02/2005US20050119344 Based on the different degree of protection that ensure the blood-vessels of the healthy and of the tumor tissue against the influence of blood-coagulation enhancing substances; formic (methane) acid; antiseptic and bactericide
06/02/2005US20050119321 2-substituted-1,3-thiazole compounds
06/02/2005US20050119320 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
06/02/2005US20050119313 Aqueous antiseptic based on bispyridiniumalkanes
06/02/2005US20050119291 Pyrimidine compounds
06/02/2005US20050119280 1-[alkyl 1-[heteroaryl )alkyl] and 1-[ aryl) alkyl]-7-( pyrimidin-4-yl) imadazo [1,2-a] pyrimidin-5(1h)-one derivatives
06/02/2005US20050119277 Benzazole derivatives for the treatment of scleroderma
06/02/2005US20050119271 Pyrimidine A2B selective antagonist compounds, their synthesis and use
06/02/2005US20050119267 Diazabicyclo alkane derivatives with nk1 antagonistic activity
06/02/2005US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase
06/02/2005US20050119246 2-(4-{[1-(2,2-dimethylpropanoyl)-4-piperidinyl]methyl}-3,5-dimethyl-1H-pyrazol-1-yl)-1-methylethylcarbamate; appetite suppressants; obesity, diabetes, feeding behavior, bulimia, anorexia nervosa and premenstrual tension; side effect reduction
06/02/2005US20050119219 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
06/02/2005US20050119216 Pharmaceutical compositions and methods relating to fucans
06/02/2005US20050119175 Method for stimulating wound healing
06/02/2005US20050119164 Immunomodulatory polymeric antigens for treating inflammatory pathogies
06/02/2005US20050118283 Skincare compositions and methods
06/02/2005US20050118232 N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
06/02/2005US20050118219 1,3,6-trihydroxy-7-methoxy-2,8-di (3-methyl-2-butenyl) xanthone; rosacea and/or telangiectasia, skin aging
06/02/2005US20050118156 Storage-stable fibrin sealant
06/02/2005US20050118133 Active agent mixture containing a plant extract of convolvulaceae
06/02/2005US20050118119 N-( omega -undecylenoyl)phenylalanine; adenylate cyclase inhibitor that has an affinity for the melanocyte specific hormone receptor
06/02/2005DE10352602A1 Kosmetisches oder therapeutisches Kombinationspräparat Cosmetic or therapeutic combination product
06/02/2005CA2547083A1 A method of inducing melanogenesis in humans with mc1r variant alleles
06/02/2005CA2546396A1 Method and composition for treatment of cutaneous lesions
06/02/2005CA2545514A1 Combination of a dpp iv inhibitor and an antiobesity or appetite regulating agent
06/01/2005EP1535925A1 4,4-Diarylbutadiene functionalized methyltrialkylsilanes and cosmetic or photoprotective dermatological compositions containing them
06/01/2005EP1535920A1 Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives
06/01/2005EP1535919A2 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
06/01/2005EP1535915A1 Furan or thiophene derivative and medicinal use thereof
06/01/2005EP1535909A2 Cyclic amine derivatives and their use as drugs
06/01/2005EP1535906A1 Nitrogen-containing compounds
06/01/2005EP1535622A1 Melanoma therapy
06/01/2005EP1535512A1 DISEASE MODEL ANIMAL CARRYING FOREIGN PPARa GENE TRANSFERRED THEREINTO AND USE THEREOF
06/01/2005EP1534847A1 Retroviral vector and stable packaging cell lines
06/01/2005EP1534834A2 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
06/01/2005EP1534753A2 Antibody peg positional isomers, compositions comprising same, and use thereof
06/01/2005EP1534725A2 Compounds and methods for inhibiting selectin-mediated function
06/01/2005EP1534708A2 Purine derivatives and their use as antiproliferative agents
06/01/2005EP1534687A1 Pyrimidine compounds
06/01/2005EP1534682A1 Novel molecules derived from noraporphine
06/01/2005EP1534681A1 Substituted quinoline ccr5 receptor antagonists
06/01/2005EP1534668A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
06/01/2005EP1534666A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex
06/01/2005EP1534663A1 N-bridged selective androgen receptor modulators and methods of use thereof
06/01/2005EP1534389A2 Pyrazolopyrimidines as kinase inhibitors
06/01/2005EP1534346A2 Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues
06/01/2005EP1534339A1 Topical anhydrous and ethanol-free ascomycin compositions
06/01/2005EP1534331A2 Membrane associated tumor endothelium markers
06/01/2005EP1534321A1 Methods of use of compounds with preptin function
06/01/2005EP1534290A2 Novel inhibitors of kinases
06/01/2005EP1534278A2 Nitrosated proton pump inhibitors, compositions and methods of use
06/01/2005EP1534267A1 Pyrrolidine derivatives as tryptase inhibitors
06/01/2005EP1534260A2 Perfluorinated fatty acids for the treatment of obesity, diabetes, hyperlipidaemia, cancer and inflammation
06/01/2005EP1534256A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
06/01/2005EP1534213A2 Water-based delivery systems
06/01/2005EP1453820B1 Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents
06/01/2005EP1404330B1 Substituted 8-arylquinoline pde4 inhibitors
06/01/2005EP1395231B1 Preparation for the removal of abnormal keratin material
06/01/2005EP1296985B1 Heteropolycyclic inhibitors
06/01/2005EP1268465B1 Triarylimidazole derivatives as cytokine inhibitors
06/01/2005EP1263884B1 Process for the preparation of micronised collagen, and its therapeutic applications
06/01/2005EP1253904B1 Use of extracts from residues left in the production of wine as cosmetic care actives for skin and hair
06/01/2005EP1233951B1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
06/01/2005EP1178977B1 Ion channel modulating agents
06/01/2005EP1143927B1 Facial tissue composition and method of use for sequestration of nasal secretion skin irritants
06/01/2005EP1062210B1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
06/01/2005EP0944310B8 Stabilized ascorbyl compositions
06/01/2005CN1622957A IFNAR2 mutants, their production and use
06/01/2005CN1622946A Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
06/01/2005CN1622941A Glutaminyl based DPIV inhibitors
06/01/2005CN1622830A Peptide-based compounds
06/01/2005CN1622820A Therapeutic cream for dermatitis
06/01/2005CN1622819A An anti-rheumatism medicament and preparation method thereof
06/01/2005CN1622818A Therapeutic lotion for dermatitis
06/01/2005CN1622817A Drinking tea for treating dermatitis
06/01/2005CN1622812A Prophylactic and therapeutic treatment of infectious and other diseases with immune effect compound
06/01/2005CN1622796A Topical anti-inflammatory compositions and methods of reducing inflammation
06/01/2005CN1621526A Recombinant adeno-associated virus for prevention and cure of I-type diabetes and use thereof
06/01/2005CN1621082A Chinese traditional medicinal composition for treating acne
06/01/2005CN1621079A Chinese traditional medicine for treating psoriasis and cutaneous pruritus
06/01/2005CN1621077A Externally applied plaster for removing freckles
06/01/2005CN1621074A Medicine for treating dermatopathy and its preparing process
06/01/2005CN1621070A Chinese patent medicine for removing whelk
06/01/2005CN1621052A Multifunctional ointment for treating trauma
1 ... 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 ... 1065